Tetrandrine Suppresses Lipopolysaccharide-Induced Microglial Activation by Inhibiting NF-κB Pathway

Yang Xue,Ying Wang,De-chun Feng,Bao-guo Xiao,Ling-yun Xu
DOI: https://doi.org/10.1111/j.1745-7254.2008.00734.x
2008-01-01
Abstract:Aim: Microglial activation has been implicated in many neurological diseases. In this study, we examined the effects of tetrandrine (TET), a major pharmacologically-active compound of Chinese herb Stephania tetrandra S Moore on microglial activation. Methods: The microglia pretreated with or without TET were activated by lipopolysaccharide (LPS) in vitro. Nitric oxide (NO) release, superoxide anion (O-2(-)) generation, as well as TNF-alpha and interleukin-6 (IL-6) production by microglia were measured afterwards. Electrophoretic mobility shift assay was performed to determine whether NF-kappa B activity in microglia was affected by TET treatment. Results: We found that TET inhibited the LPS-induced activation of microglia by decreasing the production of NO and O-2(-), consequently affecting the release of TNF-alpha and IL-6 in LPS-induced microglial activation. Such suppressive effect was accompanied by inhibiting transcription factor NF-kappa B activation. Conclusion: Our results suggest that TET might modulate LPS-induced microglial activation by inhibiting the NF-kappa B-mediated release of inflammatory factors.
What problem does this paper attempt to address?